Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2005
12/15/2005US20050277108 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
12/15/2005US20050276864 Cellular therapy to heal vascular tissue
12/15/2005US20050276861 Ex-vivo application of solid microparticulate therapeutic agents
12/15/2005US20050276822 cancer vaccines; grows as an epithelial, adherent monolayer culture; does not overexpress estrogen receptors; overexpresses her2/neu; sensitive in vitro to cyclophosphamide (4HC), etoposide and taxol; resistant in vitro to carboplatin; demonstrates karyotypic abnormalities
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276811 Natural IgM antibodies and inhibitors thereof
12/15/2005US20050276802 Comprising a variable heavy (VH) domain that has non-human hypervariable region residues incorporated into a human VH domain, said variable domain comprising a framework region (FR) substitution; anticarcinogenic agents, angiogenesis inhibitors; immunoaffinity chromatography, immunoassay; containers
12/15/2005US20050276798 with a histidine buffer and maltose; anti-HIV; higher concentrations, are storage stable, compatible with lyophilization, and safe to administer by intravenous injection
12/15/2005US20050276794 Composition and method for improving pancreatic islet cell survival
12/15/2005US20050276793 Methods for in vitro expansion of hematopoietic stem cells
12/15/2005US20050276792 Systems and methods for providing a stem cell bank
12/15/2005US20050276791 Multi-layer polymer scaffolds
12/15/2005US20050276787 Adeno-associated vector compositions for expression of factor VIII
12/15/2005DE102004025086A1 Verfahren und Vorrichtung zum Kultivieren von Stammzellen A method and apparatus for the culture of stem cells
12/15/2005DE102004024977A1 Vorrichtung zur in-vivo Charakterisierung von Zellen und Ihre Verwendung Apparatus for in vivo characterization of cells and their use
12/15/2005DE10128980B4 Gen-modifizierte alloreaktive T-Zellen, Verfahren zu ihrer Herstellung und ihre Verwendung Gene-modified alloreactive T-cells, processes for their preparation and their use
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2569486A1 For the analysis of exclusive gene expression profile using a trace amount of sample
12/15/2005CA2569485A1 Cell preservation method
12/15/2005CA2569242A1 Improved cardiomyocyte differentiation
12/15/2005CA2568781A1 Intrathymic administration of viral vectors for the induction of immune tolerance, the prevention or treatment of immunodeficiencies or autoimmune diseases
12/15/2005CA2568642A1 Cynomolgus prostate specific antigen
12/15/2005CA2568367A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2568360A1 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof
12/15/2005CA2568344A1 Novel artificial antigen presenting cells and uses therefor
12/15/2005CA2568162A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2567983A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2567578A1 In vitro techniques for use with stem cells
12/15/2005CA2567116A1 Enhancing protein expression
12/15/2005CA2566868A1 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom
12/15/2005CA2566575A1 Method of screening candidate compounds for susceptibility to biliary excretion
12/15/2005CA2566561A1 A method for producing red blood cells
12/15/2005CA2563087A1 Methods for generating neuronal cells from human embryonic stem cells and uses thereof
12/15/2005CA2562940A1 Methods of promoting cardiac cell proliferation
12/15/2005CA2561861A1 Antibodies to angiogenesis inhibiting domains of cd148
12/14/2005EP1605055A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605054A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines
12/14/2005EP1605049A2 Fibrinolytically active polypeptide
12/14/2005EP1605046A1 Stably transfected cell lines expressing human GABA-A receptors with the subunit combination alpha-2, beta-3 and gamma-2
12/14/2005EP1605044A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/14/2005EP1605040A1 Monocyte-origin multipotent cell momc
12/14/2005EP1605039A1 Dendritic cell presenting alpha-glycosylceramide derivative and a ntigen and usable in suppressing immune response
12/14/2005EP1605038A1 Method of cell culturing and cell sheet
12/14/2005EP1604674A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
12/14/2005EP1604018A1 Cartilaginous cell culture medium and the use thereof
12/14/2005EP1604017A2 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof
12/14/2005EP1604016A2 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines
12/14/2005EP1604009A2 Method for identifying risk of melanoma and treatments thereof
12/14/2005EP1603951A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies
12/14/2005EP1603946A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1527084A4 Promoters exhibiting endothelial cell specificity and methods of using same
12/14/2005EP1483370A4 Hepatocyte precursor cell lines
12/14/2005EP1438410B1 Promoters to control cell differentiation
12/14/2005EP1434988A4 Transgenic knockouts of bace-1
12/14/2005EP1357870A4 Bioadhesive cell foam film of sustained-release delivery
12/14/2005EP1326895B1 Monoclonal antibodies directed against hepatitis b viruses
12/14/2005EP1280904B1 Pain signaling molecules
12/14/2005EP1263968B1 Beta 1, 2-xylosyltransferase-gene from arabidopsis
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1177292B1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1007714B1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/14/2005EP1007666B1 Neurturin receptor
12/14/2005CN1708582A Composition for culturing multipotent stem cells and utilization of the same
12/14/2005CN1708320A Modified dendritic cells
12/14/2005CN1706939A Antinuclear polyhedron virus transgenic silkworm and generating method thereof
12/14/2005CN1706938A A-NK cell separating culture method
12/14/2005CN1706937A 3D culture method for micro carrier of sponge cell
12/14/2005CN1706936A Perfusion bioreactor
12/14/2005CN1231581C Pectin degrading enzyme from i(Bacillus licheniformis)
12/14/2005CN1231578C Attenuated virus of ox's viral diarrhea
12/14/2005CN1231491C Mammal telomerase
12/13/2005US6974900 Inbred corn line PH5WA
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974861 Conjestive heart failure; polypeptide
12/13/2005US6974698 Methods for delivering biologically active molecules into cells
12/13/2005US6974697 Composition for use in the generation and culturing of skin
12/13/2005US6974695 Complementing cell lines
12/13/2005US6974689 Nucleic acid encoding PRO211 polypeptides
12/13/2005US6974688 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like.
12/13/2005US6974686 Recombinant tryptophan mutants of influenza
12/13/2005US6974681 Cell culture performance with vanadate
12/13/2005US6974679 Support with collagen base for tissue engineering and manufacture of biomaterials
12/13/2005US6974675 Based on immune cells expressing specific proteins which bind to endothelioid cells of blood vessels in brain and muscle tissue in a specific protein combintion pattern; depositing a cell mixture on target cell surfaces
12/13/2005US6974586 Microarrays; braided meshes; tubular form; for living grafts for hernia, ganglia, coronary bypass, tissue and skin; solid phase synthesis
12/13/2005US6974572 Peptide for use in the treatment of allergic disorders
12/13/2005US6974571 Isolated stromal cells and methods of using the same
12/13/2005US6974294 Article handling system and method
12/09/2005CA2509733A1 Fermentation flask for cultivating microorganisms, a growth media and a method of use
12/08/2005WO2005116221A1 Hctla4-ig fusion protein-coding gene, recombinant vector comprising the same, and process for producing hctla4-ig fusion protein using the same
12/08/2005WO2005116216A1 Oral vaccine against protozoiasis using genetically modified plant
12/08/2005WO2005116214A2 Destructive insect-inducible promoters and uses thereof
12/08/2005WO2005116206A1 Improved nitrile hydratase
12/08/2005WO2005116199A2 Tobacco nicotine demethylase genomic clone and uses thereof
12/08/2005WO2005116194A1 Method of culturing myoblst or myoblast-like cell for forming myofiber in vitro
12/08/2005WO2005116193A1 Procedure for the growing of live tissue in a living organism
12/08/2005WO2005116192A2 Genetically engineered cells for therapeutic applications